Boxed Warnings

A boxed warning signals that a medication can cause an exceptionally serious outcome and that ordinary prescribing habits are not enough. It does not mean that every patient must avoid the drug. The clinical task is to determine whether the expected benefit justifies the risk for this patient, then build safeguards around the decision. The first exam and practice question is which regulator's label applies. In the United States, the formal term is a boxed warning, governed by FDA labelling requirements. In Canada, the corresponding regulatory device is the Serious Warnings and Precautions Box in Section 3 of the Health Canada Product Monograph. These are not interchangeable labels: FDA and Health Canada decide independently, so a warning may exist in one country, not the other, or use different wording and dates. A safe NP response follows the warning to the bedside: identify the specific harm, look for patient factors that magnify it, check the required baseline data, consider an alternative, and arrange monitoring before the first dose. Patient counselling and documentation should show what risk was discussed, what symptoms require...